The global antibody-mediated rejection prevention market is poised for remarkable expansion, reflecting the increasing demand for innovative solutions in organ transplant care. In 2023, the market is valued at USD 89 million, and it is projected to grow at a compelling compound annual growth rate (CAGR) of 16% through 2033. By the end of this …